AGIO
Agios Pharmaceuticals, Inc.
32.90$
-3.8%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -4.0% | +15.3% | +5.2% | +4.1% | +19.7% | -18.7% | +42.7% | +3.4% | +55.0% | +3.9% | +115.7% | – | |
| – | +214.2% | -0.7% | +56.4% | -74.6% | +60.9% | +87.5% | +25.3% | +3.1% | +3.0% | -14.7% | +11.7% | – | |
| – | -24.4% | +21.5% | -11.1% | +48.0% | +15.8% | -32.8% | +49.2% | +3.5% | +71.2% | +7.4% | +131.1% | – | |
| – | -7.0% | -11.6% | +12.7% | -4.4% | +14.3% | -13.7% | +26.9% | -5.8% | +1.6% | -8.1% | +26.3% | – | |
| – | +36.7% | -12.2% | +14.6% | +8.4% | +34.1% | -19.7% | +10.5% | -10.0% | +25.0% | -6.4% | +6.7% | – | |
| – | +3.5% | -11.8% | +13.3% | -0.3% | +21.2% | -16.0% | +20.8% | -7.2% | +9.2% | -7.5% | +18.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -110.5% | – | – | – | – | – | – | – | |
| – | – | -4.0% | – | – | -116.7% | – | – | – | – | – | – | – | |
| – | – | – | – | – | -110.2% | – | – | – | – | – | – | – | |
| – | – | – | – | – | -110.4% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.